Re: Editorial comment on Role of marker lesion when applying intravesical instillations of IL-2 for non-muscle-invasive bladder cancer comparison of the therapeutic effects in two pilot studies: D. P. Wood J Urol 2014; 191: 348

J Urol. 2015 Feb;193(2):734-5. doi: 10.1016/j.juro.2014.07.122. Epub 2014 Nov 11.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Biomarkers, Tumor / analysis*
  • Female
  • Humans
  • Interleukin-2 / therapeutic use*
  • Male
  • Neoplasm Recurrence, Local / mortality*
  • Urinary Bladder Neoplasms / mortality*

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Interleukin-2